Keywords: scotia, boosted, surprise, phase, iii, results, foscan

Scotia boosted by surprise Phase III results for Foscan

Article | 01 September 1999

The share price of Scottish biotechnology company Scotia rose 12.5 penceto 112.50 pence ($178.81) last week on unexpectedly good Phase III trial results ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Photofrin

Porfimer Sodium

Go to drug listing